Skip to search formSkip to main contentSkip to account menu

Neovastat

Known as: Neovastat/AE-941 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Vascular endothelial growth factor (VEGF) contributes to airway inflammation and angiogenesis in asthma. Hypoxia inducible factor… 
2004
2004
Hypertension and cancer are two leading diseases in the world. Often they coexist in patients. They share some common… 
2004
2004
4547 Background: Immunotherapy (IT) remains first-line treatment for metastatic renal cell carcinoma (RCC). For patients (pts… 
2003
2003
Background: Æ-941 (Neovastat) is an angiogenesis inhibitor noted to have antiinflammatory properties. Objective: We tested… 
2002
2002
Neovastat (Æ-941), a naturally occurring multifunctional antiangiogenic agent, has been shown to inhibit key components of the… 
2001
2001
AE-941 (Neovastat) is a naturally occurring product extracted from cartilage and has antiangiogenic properties. It has reached… 
Review
2000
Review
2000
Angiogenesis is known to be a critical process for the tumor growth and metastasis. There are many indigenous role-players in…